Company Search:
Advanced Search
Sponsored Links
Aduro Biotech Inc Company Snapshot
Aduro Biotech Inc operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Aduro Biotech Inc with three other companies in this sector in the United States: Pfenex Inc (2018 sales of $14.86 million of which 100% was Biotechnology), Arvinas Inc ($14.32 million of which 100% was Biopharmaceutical), and Wave Life Sciences Ltd ($14.41 million of which 100% was Pharmaceutical).

Sales Analysis. During the year ended December of 2018, sales at Aduro Biotech Inc were $15.09 million. This is a decrease of 12.5% versus 2017, when the company's sales were $17.24 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Aduro Biotech Inc
  Stock Performance Chart for Aduro Biotech Inc
  Stock Data: Recent Stock Performance:
  Current Price (1/17/2020): 1.40
(Figures in U.S. Dollars)
1 Week 17.6%   13 Weeks 40.3%  
4 Weeks 38.6%   52 Weeks -48.1%  
Aduro Biotech Inc Key Data:
  Ticker: ADRO Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 15,087,000
(Year Ending Jan 2019).
Employees: 152
  Currency: U.S. Dollars Market Cap: 112,720,243
  Fiscal Yr Ends: December Shares Outstanding: 80,514,459
  Share Type: Common Closely Held Shares: 25,386,483
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.